Condition: Healthy Adult Male · Sponsor: Bioiberica
The present clinical study has been designed to evaluate the effect of Collavant® n2 at a daily dose of 40 mg on joint function and performance in healthy, amateur male runners with exercise-induced knee discomfort.
This description comes directly from the study's public registry record.
Mónica García-López, Doctor · +34 93 765 03 90 · monicagarcia@bioiberica.com
Always discuss trial participation with your own doctor first.
| Universidad Politecnica de Madrid | Madrid, Madrid, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07561203